Impact of a Novel Radiation Protection System on Door-to-Balloon Time During STEMI Intervention

新型辐射防护系统对STEMI介入治疗中从入院到球囊扩张时间的影响

阅读:2

Abstract

BACKGROUND: Prolonged radiation exposure remains a critical occupational hazard in the catheterization lab, typically mitigated by lead aprons, which contribute to orthopedic injury. Recent innovations like the Rampart M1128 enhanced radiation protection system (Rampart IC) aim to reduce these risks, but their impact on door-to-balloon (D2B) time in ST-elevation myocardial infarction (STEMI) has not been evaluated. METHODS: We conducted a single-center retrospective cohort study comparing D2B times among 174 STEMI patients undergoing percutaneous coronary intervention: 87 treated using lead aprons and 87 treated utilizing the Rampart M1128 system. Patients were randomly selected from a pool of 298. Analyses were adjusted for potential confounders, including bleeding, use of vasopressors, intubation, mechanical support, electrical instability, access type, and prior revascularization. RESULTS: Unadjusted median D2B time was 31.0 minutes in the Rampart group vs 31.1 minutes in the lead apron group. Adjusted analysis yielded a mean D2B difference of 1.51 minutes (95% CI, -0.86 to 3.87; P = .21), well within the prespecified 5-minute noninferiority margin. No statistically significant differences were observed across expanded models or one-at-a-time covariate models. The presence of shock or respiratory failure did not prolong D2B times in the Rampart group. CONCLUSIONS: Implementation of an enhanced radiation protection system was noninferior to standard lead apron use regarding D2B time in STEMI patients. This suggests such systems can enhance operator safety without compromising the quality of patient care. Broader adoption may be justified to reduce occupational harm while maintaining high-quality cardiovascular outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。